Banks
-
LBBW has hired an origination and syndication banker for its SSA team in Stuttgart, which now comprises five people. -
Investor demand for more new issue premium forced China’s Citic Securities Co to price a smaller-than-expected $300m bond on Monday.
-
China Vanke Co rode the positive momentum that followed the truce in the China and US trade war, raising $630m after an aggressive tightening in price. But the movements in the US Treasury market, including a curve inversion between three and five year notes, hit the secondary performance of the company’s bond.
-
Chinese online consumer lender 360 Finance is preparing to launch its New York Stock Exchange IPO on Wednesday, targeting around $100m, according to a source close to the deal.
-
The Republic of Indonesia managed to raise $3bn across three tranches of notes in its annual dollar funding exercise, but paid a double-digit premium to attract investors cautious about the sovereign credit.
-
Tencent Music Entertainment Group has begun bookbuilding for its long-awaited $1.23bn IPO in the US, around two months after first gauging investor appetite.
-
Luzhou City Commercial Bank and Ever Sunshine Lifestyle Services Group kicked off bookbuilding for their respective IPOs as they aim to cross the finish line before the end of the year.
-
Red chip issuer China Gas Holdings plans to raise up to Rmb1.3bn ($189m) from a new Panda bond this month before its issuance programme expires.
-
ICBC International Holdings, a wholly-owned Hong Kong subsidiary of Industrial and Commercial Bank of China, is about to close a dual-tranche borrowing of between $100m and $200m.
-
HSBC has tapped two of its veteran bankers as Guangdong co-chief executives, as part of the bank’s push in the Pearl River Delta (PRD) region.
-
Eurofima received strong demand for its first green bond on Monday, with the leads attributing the success to the timing of the transaction.
-
The UK’s GlaxoSmithKline has agreed to buy US oncology company Tesaro for $5.1bn, as 'long overdue' consolidation in the pharmaceutical sector continues apace.
